Synchrony Medical's LibAirty system for addressing mucus obstruction in COPD patients gained FDA clearance in July 2025.
Novel, experimental treatment for emphysema may offer promising results for patients looking to breathe easier ...
Both dupilumab and mepolizumab were originally approved for asthma but were subsequently studied in patients with COPD who continue to experience symptoms and moderate-to-severe exacerbations despite ...
One patient could only walk 15 to 20 steps before needing to get back on her oxygen, making it difficult to find motivation to engage in daily activities. Another patient struggled with severe ...
Lung cancer screening saves lives by detecting cancer early when it is most treatable. But what many people don’t realize is that the same low-dose CT scans used to screen for lung cancer can also ...
New FDA-approved medical treatments can be transformative for patients and families, often providing them with more years to live and an enhanced quality of life. 1 Delivering timely, high-quality ...
Researchers at National Jewish Health evaluating computerized tomography (CT) scans of emphysema progression in the COPDGene study showed that, during a span of 10 years, participants with ...
PHILADELPHIA (WPVI) -- For people with emphysema, breathing in is hard because the lungs can't expand properly. In this week's Moves in Medicine, we learn about a procedure letting some emphysema ...
COPD treatments aim to improve patients' quality of life, with options including medication, rehabilitation, and invasive procedures. Emphysema significantly impacts patients' daily activities due to ...
Surgery in which doctors remove diseased portions of the lungs clearly helps some people with emphysema, a new study finds. But the likelihood of benefit depends on the location of the damaged tissues ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In those with and those without emphysema, patients ...
Inhaled maintenance therapy is underused among hospitalized patients with COPD in China, even in those with frequent prior hospitalizations.